In a major step towards strengthening the pharmaceutical sector in the Kingdom, EVA Pharma has signed a strategic partnership with the Saudi Authority for Industrial Cities and Technology Zones.

The agreement includes the establishment of five state-of-the-art pharmaceutical manufacturing facilities in Saudi Arabia.

The new plants will be equipped with the latest artificial intelligence technologies, eco-friendly water management practices, and sustainable green chemistry principles. EVA Pharma’s goal is to provide high-quality, locally produced medications across multiple therapeutic areas, ensuring sustainable supply and meeting the diverse healthcare needs of patients in the Kingdom.

This initiative aligns with Saudi Arabia’s vision to boost local pharmaceutical production, enhance healthcare security, and reduce reliance on imported medicines.